Psychosis associated with interferon alfa therapy for chronic hepatitis B

Annals of Pharmacotherapy

Volumn 37, Issue 3, 2003, Pages 384-387

  Tamam, Lut ^a   Yerdelen, Deniz ^a   Ozpoyraz, Nurgul ^a   Massari, Jorge R Miranda ^b   Marcotte, Alain ^b  

^a CUKUROVA UNIVERSITY   (Turkey)

^b Psiki yatri Anabilim Dali ^*

Author keywords

Chronic hepatitis B; Interferon alfa; Psychosis

Indexed keywords

ALPHA INTERFERON; OLANZAPINE;

ADULT; AGITATION; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; DELIRIUM; DELUSION; DEPRESSION; DISEASE COURSE; HALLUCINATION; HEPATITIS B; HUMAN; MALE; MANIA; PARANOIA; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR;

EID: 0347927555     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C266     Document Type: Article

References (18)

1. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alpha interferon. J Hepatol 1996;24:38-47.
2. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000;157:867-76.
3. Valentine AD. Managing the neuropsychiatric adverse effects of interferon treatment. Biodrugs 1999;11:229-37.
4. Lerner DM, Stoudemire A, Rosenstein DL. Neuropsychiatric toxicity associated with cytokine therapies. Psychosomatics 1999;40:428-35.
5. Malek-Ahmadi P. Mood disorders associated with interferon treatment: theoretical and practical considerations. Ann Pharmacother 2001;35:489-95.
6. Hosoda S, Takimura H, Shibayama M, Kanamura H, Ikeda K, Kumada H. Psychiatric symptoms related to intefferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurosci 2000;54:565-72.
7. Ho SB, Nguyen H, Tetrick LL, Opitz GA, Basara ML, Dieperink E. Influence of psychiatric diagnoses on intefferon-α treatment for chronic hepatitis C in a veteran population. Am J Gastroenterol 2001;96:157-64.
8. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, et al. Psychiatric complication of long term interferon alpha therapy. Arch Intern Med 1987;147:1577-80.
9. Pariante CM, Orru MG, Baita A, Farci MG, Carpiniello B. Treatment with interferon alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999;354:131-2.
10. Alfindag A, Ozbulut O, Ozen S, Ucmak H. Interferon-alfa-induced mood disorder with manic features. Gen Hosp Psychiatry 2001;23:168-70.
11. Monji A, Yoshida I, Tashiro K, Hayashi Y. Tashiro N. A case of persistent manic depressive illness induced by interferon-alpha in the treatment of chronic hepatitis C. Psychosomatics 1993;39:562-4.
12. Fukunishi K, Tanaka H, Maruyama J, Takahashi H, Kitagishi H, Ueshima T, et al. Burns in a suicide attempt related to psychiatric effects of interferon. Burns 1998;24:581-3.
13. Prior TI, Chue PS. Psychotic depression occurring after stopping interferon-α. J Clin Psychopharmacol 1999;19:385-6.
14. Bozikas V, Petrikis P, Balla A, Karavatos A. An interferon-α induced psychotic disorder in a patient with chronic hepatitis C. Eur Psychiatry 2001;16:136-7.
15. Schafer M, Boetsch T. Laakmann G. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C. Addiction 2000;95:1101-4.
16. Howes OD, McKenzie KJ. Manic psychosis induced by long term alpha-interferon treatment for hepatitis C. Int J Psych Clin Pract 2000;4:161-2.
17. Maggi F, Giorgi M, Fornai C, Morrica A, Vatteroni ML, Pistello M, et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 1999;5:319-23.
18. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.